News
7hon MSN
GDF-15 and eGFRdiff: Blood markets may help predict kidney risk and survival in diabetes mellitus
Kidney complications in diabetes often progress silently, putting patients at risk of life-threatening outcomes long before ...
News-Medical.Net on MSN5h
New blood markers predict kidney disease and mortality in diabetes
Kidney complications in diabetes often progress silently, putting patients at risk of life-threatening outcomes long before ...
The FDA approved pegcetacoplan (EMPAVELI; Apellis Pharmaceuticals) as the first treatment for patients aged 12 and older with the rare, severe kidney diseases C3 glomerulopathy (C3G) and primary ...
Verywell Health on MSN5h
Everything You Need to Know About C3G and IC-MPGN
Medically reviewed by David Ozeri, MD C3G (Complement 3 Glomerulopathy) and IC-MPGN (Immune Complex Membranoproliferative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback